
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1102 | 1091 | 1124 | 1105 | 1416 | 2025 |
Fund Return | 10.19% | 9.06% | 12.39% | 3.38% | 7.2% | 7.31% |
Place in category | 327 | 257 | 484 | 360 | 248 | 42 |
% in Category | 47 | 37 | 72 | 65 | 52 | 15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet CH Institutional Swiss EquZD | 2.09B | 10.28 | 3.87 | 7.82 | ||
Pictet CH Institutional Swiss EquiP | 2.09B | 10.16 | 3.18 | 7.09 | ||
Pictet CH Institutional Swiss EquiZ | 2.09B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquID | 2.09B | 4.62 | -3.37 | 6.34 | ||
Pictet CH Institutional Swiss EquPD | 2.09B | 4.41 | -3.57 | 6.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.51B | 12.09 | 5.90 | 7.10 | ||
Pictet CH Institutional Swiss EquiP | 2.09B | 10.16 | 3.18 | 7.09 | ||
Pictet CH Institutional Swiss EquZD | 2.09B | 10.28 | 3.87 | 7.82 | ||
Pictet CH Institutional Swiss EquiZ | 2.09B | 8.90 | 2.54 | 8.57 | ||
UBS CH Equity Fund Swiss Income CHF | 2.54B | 8.29 | 0.69 | 5.71 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 13.13 | 261.80 | -6.00% | |
Nestle | CH0038863350 | 10.92 | 87.36 | -3.64% | |
Novartis | CH0012005267 | 9.90 | 92.03 | -5.42% | |
ABB | CH0012221716 | 6.61 | 41.05 | -4.27% | |
Zurich Insurance Group | CH0011075394 | 6.20 | 565.40 | -6.95% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review